GB0021859D0 - Methods - Google Patents

Methods

Info

Publication number
GB0021859D0
GB0021859D0 GBGB0021859.4A GB0021859A GB0021859D0 GB 0021859 D0 GB0021859 D0 GB 0021859D0 GB 0021859 A GB0021859 A GB 0021859A GB 0021859 D0 GB0021859 D0 GB 0021859D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0021859.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB0021859.4A priority Critical patent/GB0021859D0/en
Publication of GB0021859D0 publication Critical patent/GB0021859D0/en
Priority to PCT/GB2001/003901 priority patent/WO2002020054A2/en
Priority to AU2001284215A priority patent/AU2001284215A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
GBGB0021859.4A 2000-09-06 2000-09-06 Methods Ceased GB0021859D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0021859.4A GB0021859D0 (en) 2000-09-06 2000-09-06 Methods
PCT/GB2001/003901 WO2002020054A2 (en) 2000-09-06 2001-08-31 Methods of treatment and diagnosis of hcv infection in cns based on magnetic resonance spectroscopy
AU2001284215A AU2001284215A1 (en) 2000-09-06 2001-08-31 Methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021859.4A GB0021859D0 (en) 2000-09-06 2000-09-06 Methods

Publications (1)

Publication Number Publication Date
GB0021859D0 true GB0021859D0 (en) 2000-10-18

Family

ID=9898950

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0021859.4A Ceased GB0021859D0 (en) 2000-09-06 2000-09-06 Methods

Country Status (3)

Country Link
AU (1) AU2001284215A1 (en)
GB (1) GB0021859D0 (en)
WO (1) WO2002020054A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1233976A4 (en) * 1999-11-17 2003-06-11 Jiuping Ji Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
FR2884522A1 (en) * 2005-04-19 2006-10-20 Larissa Balakireva METHOD OF INHIBITING TRANSLATION AND / OR REPLICATION OF AN RNA SEQUENCE BY MULTIMERIZATION OF ONE OF ITS NON-ENCODING RNA REGIONS REPLYED

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
AU5285899A (en) * 1998-07-21 2000-02-14 Connex Gesellschaft Zur Optimierung Von Forschung Und Entwicklung Mbh Anti hepatitis c virus antibody and uses thereof

Also Published As

Publication number Publication date
WO2002020054A3 (en) 2002-05-16
AU2001284215A1 (en) 2002-03-22
WO2002020054A2 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU3391801A (en) Pyridinylimidazoles
AU6803901A (en) Bis-arylsulfones
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
AU9385201A (en) Sulfonylguanidine
DE50008626D1 (en) Substituierte aminomethyl-phenyl-cyclohexanderivate
AU6619001A (en) Liquid-pourers
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
GB0015923D0 (en) Methods
AU9187601A (en) Triazolo-epothilones
AU4686401A (en) Hypotensors
DE50100877D1 (en) Thermoverformbares verbundmaterial
DE50006446D1 (en) Otoplastik
AU4831301A (en) Gm-negative ehv-mutants
GB0026094D0 (en) Methods
GB0031744D0 (en) Methods
AU8756801A (en) Thienopyrrolidinones
DE50003404D1 (en) Multi-master-bus-system
DE50103809D1 (en) Hydrocephalusventil
DE50013705D1 (en) Otoplastik
GB0031390D0 (en) Methods
GB0001005D0 (en) Methods
GB0102454D0 (en) Methods
GB0021859D0 (en) Methods
GB0024510D0 (en) Methods
GB0007989D0 (en) Methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)